Park, Y.-A.; Lee, A.K.; Barmanray, R.D.; Gao, F.; Fourlanos, S.; Gilfillan, C.
Duration of DKA and Insulin Use in People with and Without SGLT2 Inhibitor Medications. Medicines 2025, 12, 21.
https://doi.org/10.3390/medicines12030021
AMA Style
Park Y-A, Lee AK, Barmanray RD, Gao F, Fourlanos S, Gilfillan C.
Duration of DKA and Insulin Use in People with and Without SGLT2 Inhibitor Medications. Medicines. 2025; 12(3):21.
https://doi.org/10.3390/medicines12030021
Chicago/Turabian Style
Park, Yeung-Ae, Anya Kitt Lee, Rahul D. Barmanray, Frank Gao, Spiros Fourlanos, and Chris Gilfillan.
2025. "Duration of DKA and Insulin Use in People with and Without SGLT2 Inhibitor Medications" Medicines 12, no. 3: 21.
https://doi.org/10.3390/medicines12030021
APA Style
Park, Y.-A., Lee, A. K., Barmanray, R. D., Gao, F., Fourlanos, S., & Gilfillan, C.
(2025). Duration of DKA and Insulin Use in People with and Without SGLT2 Inhibitor Medications. Medicines, 12(3), 21.
https://doi.org/10.3390/medicines12030021